StocktradeC

ABBV long setup

ロング
NYSE:ABBV   AbbVie Inc.
ABBV’s innovation outlook is trending up based on a current score of 70 out of 99, outperforming sector average. Jobs growth over the past year has decreased and insiders sentiment is positive. ABBV is an Outperformer in terms of sustainability. It is most exposed to AstraZeneca PLC as its supplier. Over the past 4 quarters ABBV beat earnings estimates 3 times and it pays dividend higher than its peers.
For more analysis and articles visit our website.
免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。